ABBV ready for shortABBV seems ready for short, RSI already broken trend line.
Details are on chart.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.11 USD
4.24 B USD
56.33 B USD
1.76 B
About AbbVie Inc.
Sector
Industry
CEO
Robert A. Michael
Website
Headquarters
North Chicago
Founded
2011
ISIN
US00287Y1091
FIGI
BBG01LGTZ0N7
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where ABBV is featured.
Frequently Asked Questions
The current price of ABBV is 189.41 USD — it has decreased by −2.11% in the past 24 hours. Watch AbbVie, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BVL exchange AbbVie, Inc. stocks are traded under the ticker ABBV.
We've gathered analysts' opinions on AbbVie, Inc. future price: according to them, ABBV price has a max estimate of 270.00 USD and a min estimate of 195.00 USD. Watch ABBV chart and read a more detailed AbbVie, Inc. stock forecast: see what analysts think of AbbVie, Inc. and suggest that you do with its stocks.
ABBV reached its all-time high on Sep 6, 2024 with the price of 193.50 USD, and its all-time low was 160.10 USD and was reached on May 9, 2024. View more price dynamics on ABBV chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ABBV stock is 2.16% volatile and has beta coefficient of 0.39. Track AbbVie, Inc. stock price on the chart and check out the list of the most volatile stocks — is AbbVie, Inc. there?
Today AbbVie, Inc. has the market capitalization of 388.63 B, it has decreased by −2.77% over the last week.
Yes, you can track AbbVie, Inc. financials in yearly and quarterly reports right on TradingView.
AbbVie, Inc. is going to release the next earnings report on Oct 24, 2025. Keep track of upcoming events with our Earnings Calendar.
ABBV earnings for the last quarter are 2.97 USD per share, whereas the estimation was 2.88 USD resulting in a 3.12% surprise. The estimated earnings for the next quarter are 3.26 USD per share. See more details about AbbVie, Inc. earnings.
AbbVie, Inc. revenue for the last quarter amounts to 15.42 B USD, despite the estimated figure of 15.03 B USD. In the next quarter, revenue is expected to reach 15.56 B USD.
ABBV net income for the last quarter is 928.00 M USD, while the quarter before that showed 1.28 B USD of net income which accounts for −27.27% change. Track more AbbVie, Inc. financial stats to get the full picture.
Yes, ABBV dividends are paid quarterly. The last dividend per share was 1.64 USD. As of today, Dividend Yield (TTM)% is 2.94%. Tracking AbbVie, Inc. dividends might help you take more informed decisions.
AbbVie, Inc. dividend yield was 3.54% in 2024, and payout ratio reached 263.15%. The year before the numbers were 3.87% and 220.33% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 26, 2025, the company has 55 K employees. See our rating of the largest employees — is AbbVie, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AbbVie, Inc. EBITDA is 26.75 B USD, and current EBITDA margin is 44.40%. See more stats in AbbVie, Inc. financial statements.
Like other stocks, ABBV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AbbVie, Inc. stock right from TradingView charts — choose your broker and connect to your account.